文献速递肾小球疾病

通过免疫球蛋白库测序重新审视伴单克隆免疫球蛋白沉积的增生性肾小球肾炎

Revisiting proliferative glomerulonephritis with monoclonal immunoglobulin deposits through immunoglobulin repertoire sequencing.
PubMed 文献 · Kidney Int · 2025-09-24

研究纳入56例伴单克隆免疫球蛋白沉积的增生性肾小球肾炎(PGNMID)患者,用高灵敏度免疫球蛋白库测序(RACE-RepSeq)检测骨髓克隆,并用抗轻链可变区抗体评估沉积物单克隆性。RACE-RepSeq仅在全队列23%患者中检出与沉积Ig对应的骨髓克隆;以IgG3型为主(41/56,73%),IgG3κ沉积占33/56(59%),而IgG3型中仅4/41(9.8%)检出IgG3分泌性骨髓克隆;7例克隆阴性IgG3κ病例的肾小球沉积物对全部测试Vκ亚群均染色,排除其单克隆性质;24例未检出克隆者的免疫球蛋白库分析未见向沉积同种型偏移,但IgG1比例升高,提示感染触发。

要点

  • RACE-RepSeq仅在全队列23%的PGNMID患者中检出与沉积Ig对应的骨髓克隆。
  • PGNMID-IgG3为主要亚型(41/56,73%),IgG3κ沉积占33/56(59%)。
  • 7例克隆阴性IgG3κ病例的肾小球沉积物对全部测试Vκ亚群均染色,排除单克隆性。

核心结论

  • 作者认为PGNMID是异质性疾病,主要亚型常涉及肾毒性IgG3的寡克隆或多克隆产生,可能并非源于克隆性B细胞疾病,此类病例不应再归类为MGRS。

研究设计与样本

  • 研究回顾性分析56例PGNMID患者的队列,聚焦血液学特征,采用骨髓RNA的高通量免疫球蛋白库测序(RACE-RepSeq)检测离散的潜在克隆,并用抗轻链可变区亚群特异性抗体通过免疫荧光评估肾脏沉积物的单克隆性。

主要发现

  • RACE-RepSeq仅在全队列23%的患者中检出与沉积Ig对应的骨髓克隆。
  • PGNMID-IgG3为主要亚型(41/56,73%),IgG3κ沉积占33/56(59%)。
  • 克隆性疾病低患病率由PGNMID-IgG3病例驱动,仅4/41(9.8%)患者经RACE-RepSeq检出IgG3分泌性骨髓克隆。
  • 在全部7例经抗轻链可变区抗体免疫荧光研究的克隆阴性PGNMID-IgG3κ病例中,肾小球沉积物对全部测试Vκ亚群均染色,排除其单克隆性质。
  • 与对照个体相比,24例未检出克隆患者的免疫球蛋白库分析未检测到向沉积同种型的偏移,但显示IgG1比例升高,提示感染触发。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) is classified within the spectrum of monoclonal gammopathy of renal significance (MGRS). However, PGNMID features an unexpected low rate of detectable monoclonal gammopathy, questioning the reality of an underlying clonal disorder in most cases. METHODS: We reviewed a cohort of 56 patients with PGNMID focusing on hematological characteristics. To detect discrete underlying clones, we used a highly sensitive high-throughput immunoglobulin (Ig) repertoire sequencing assay from RNA bone marrow (RACE-RepSeq). We also challenged the monoclonality of kidney deposits using immunofluorescence with antibodies specific for light chain (LC) variable region subgroups. RESULTS: RACE-RepSeq detected a bone marrow clone corresponding to the deposited Ig in only 23% of the whole cohort. As previously reported, PGNMID-IgG3 was the predominant subtype (41/56, 73%), with an over-representation of IgG3 kappa deposits (33/56, 59%). The low prevalence of clonal disorders was driven by PGNMID-IgG3 cases, with only 4/41 (9.8%) patients showing an IgG3-secreting bone marrow clone by RACE-RepSeq. In all seven clone-negative PGNMID-IgG3 kappa cases studied by immunofluorescence with anti-LC variable domain antibodies, glomerular deposits stained for all tested Vκ subgroups, ruling out their monoclonal nature. Compared to control individuals, immunoglobulin repertoire analyses in 24 patients without a detectable clone failed to detect any bias toward the deposited isotype, but showed increased IgG1 representation, suggesting an infectious trigger. CONCLUSIONS: Our results suggest that PGNMID is a heterogeneous condition. The predominant subtype most often involves oligoclonal or polyclonal production of nephrotoxic IgG3 and may not derive from a clonal B-cell disorder. Such cases should no longer be classified as MGRS.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Javaugue V, Pascal V, Nasr SH, et al. Revisiting proliferative glomerulonephritis with monoclonal immunoglobulin deposits through immunoglobulin repertoire sequencing. Kidney Int. 2025. PMID: 41005569. doi:10.1016/j.kint.2025.07.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。